BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2051731)

  • 1. Potential role of PFOB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necrosis.
    Munzing D; Mattrey RF; Reznik VM; Mitten RM; Peterson T
    Kidney Int; 1991 Apr; 39(4):733-9. PubMed ID: 2051731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction.
    Coley BD; Mattrey RF; Roberts A; Keane S
    Kidney Int; 1991 Apr; 39(4):740-5. PubMed ID: 2051732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AUR Memorial Award 1990. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB.
    Coley BD; Mattrey RF; Mitten RM; Peterson T
    Invest Radiol; 1990 Dec; 25(12):1287-93. PubMed ID: 2279907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
    Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
    Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacy.
    Mattrey RF; Brown JJ; Shelton RE; Ogino MT; Johnson KK; Mitten RM
    Invest Radiol; 1991 Sep; 26(9):792-8. PubMed ID: 1938289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonographic enhancement of Doppler signals and perfused tissues with perfluorooctylbromide.
    Mattrey RF
    Invest Radiol; 1990 Sep; 25 Suppl 1():S158-9. PubMed ID: 2283238
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast-enhanced sonography in early kidney graft dysfunction.
    Benozzi L; Cappelli G; Granito M; Davoli D; Favali D; Montecchi MG; Grossi A; Torricelli P; Albertazzi A
    Transplant Proc; 2009 May; 41(4):1214-5. PubMed ID: 19460520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CME Sonography 99: Kidney Echo Changes].
    Tuma J
    Praxis (Bern 1994); 2021 Jun; 110(8):461-468. PubMed ID: 34107761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of myocardial function during ischemia with intracoronary perfluoroocytlbromide (Oxygent).
    Ogilby JD; Noma S; DiLoretto G; Stets G
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):973-7. PubMed ID: 1391542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted combination and anti-inflammatory effects of anti-intercellular adhesion molecule 1 targeted perfluorooctylbromide particles on myocardial ischemia-reperfusion injury in rat model].
    Shang Y; Tang H; Wei X; Hou J; Wang L; Li G; Song H; Fang H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Mar; 27(3):340-4. PubMed ID: 23672138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of evolving acute tubular necrosis with renal 23Na MRI: studies in rats.
    Maril N; Margalit R; Rosen S; Heyman SN; Degani H
    Kidney Int; 2006 Feb; 69(4):765-8. PubMed ID: 16518333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CME Sonography 99/Answers: Kidney Echo Changes].
    Tuma J
    Praxis (Bern 1994); 2021 Jul; 110(9):510-511. PubMed ID: 34231382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
    Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
    Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
    Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
    Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.
    Mattrey RF; Long DM; Peck WW; Slutsky RA; Higgins CB
    J Comput Assist Tomogr; 1984 Aug; 8(4):739-44. PubMed ID: 6736376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung growth induced by prenatal instillation of perfluorocarbon into the fetal rabbit lung.
    Muensterer OJ; Till H; Bergmann F; Klis VJ; Metzger R; Deprest JA; Simbruner G
    Pediatr Surg Int; 2004 Apr; 20(4):248-52. PubMed ID: 15083328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.
    Mattrey RF; Andrè M; Campbell J; Mitten R; Multer F; Hackney D; Long DM; Higgins CB
    Invest Radiol; 1984; 19(5):438-46. PubMed ID: 6511250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent.
    André M; Nelson T; Mattrey R
    Invest Radiol; 1990 Sep; 25(9):983-7. PubMed ID: 2211056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents.
    Mattrey RF; Leopold GR; vanSonnenberg E; Gosink BB; Scheible FW; Long DM
    J Ultrasound Med; 1983 Apr; 2(4):173-6. PubMed ID: 6854723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Computed tomographic studies on density kinetics after the bolus injection and infusion of perfluorooctylbromide (PFOB). Animal experimental studies].
    Adam G; Günther RW; Prescher A; Goertz H; Schiffer C; Bruchmüller K; Limmer J
    Rofo; 1992 May; 156(5):487-91. PubMed ID: 1596555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.